India
· Delayed Price · Currency is INR Sanofi India Statistics
Total Valuation
Sanofi India has a market cap or net worth of INR 142.52 billion. The enterprise value is 139.87 billion.
| Market Cap | 142.52B |
| Enterprise Value | 139.87B |
Important Dates
The next estimated earnings date is Friday, July 25, 2025.
| Earnings Date | Jul 25, 2025 |
| Ex-Dividend Date | Apr 25, 2025 |
Share Statistics
Sanofi India has 23.03 million shares outstanding.
| Current Share Class | 23.03M |
| Shares Outstanding | 23.03M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | +0.00% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 26.47% |
| Float | 9.07M |
Valuation Ratios
The trailing PE ratio is 45.43 and the forward PE ratio is 31.90.
| PE Ratio | 45.43 |
| Forward PE | 31.90 |
| PS Ratio | 7.08 |
| PB Ratio | 16.56 |
| P/TBV Ratio | 16.59 |
| P/FCF Ratio | 33.53 |
| P/OCF Ratio | 30.88 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 28.43, with an EV/FCF ratio of 32.90.
| EV / Earnings | 33.84 |
| EV / Sales | 6.95 |
| EV / EBITDA | 28.43 |
| EV / EBIT | 30.82 |
| EV / FCF | 32.90 |
Financial Position
The company has a current ratio of 1.57, with a Debt / Equity ratio of 0.02.
| Current Ratio | 1.57 |
| Quick Ratio | 0.78 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | 0.04 |
| Debt / FCF | 0.05 |
| Interest Coverage | 302.60 |
Financial Efficiency
Return on equity (ROE) is 33.45% and return on invested capital (ROIC) is 29.64%.
| Return on Equity (ROE) | 33.45% |
| Return on Assets (ROA) | 17.06% |
| Return on Invested Capital (ROIC) | 29.64% |
| Return on Capital Employed (ROCE) | 50.85% |
| Revenue Per Employee | 16.43M |
| Profits Per Employee | 3.37M |
| Employee Count | 1,225 |
| Asset Turnover | 1.21 |
| Inventory Turnover | 1.71 |
Taxes
In the past 12 months, Sanofi India has paid 1.18 billion in taxes.
| Income Tax | 1.18B |
| Effective Tax Rate | 27.28% |
Stock Price Statistics
The stock price has decreased by -9.70% in the last 52 weeks. The beta is 0.07, so Sanofi India's price volatility has been lower than the market average.
| Beta (5Y) | 0.07 |
| 52-Week Price Change | -9.70% |
| 50-Day Moving Average | 6,140.06 |
| 200-Day Moving Average | 6,149.77 |
| Relative Strength Index (RSI) | 41.39 |
| Average Volume (20 Days) | 395 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Sanofi India had revenue of INR 20.13 billion and earned 4.13 billion in profits. Earnings per share was 179.46.
| Revenue | 20.13B |
| Gross Profit | 10.19B |
| Operating Income | 4.54B |
| Pretax Income | 4.31B |
| Net Income | 4.13B |
| EBITDA | 4.85B |
| EBIT | 4.54B |
| Earnings Per Share (EPS) | 179.46 |
Balance Sheet
The company has 2.84 billion in cash and 193.00 million in debt, giving a net cash position of 2.65 billion or 114.85 per share.
| Cash & Cash Equivalents | 2.84B |
| Total Debt | 193.00M |
| Net Cash | 2.65B |
| Net Cash Per Share | 114.85 |
| Equity (Book Value) | 8.61B |
| Book Value Per Share | 373.68 |
| Working Capital | 4.08B |
Cash Flow
In the last 12 months, operating cash flow was 4.62 billion and capital expenditures -364.00 million, giving a free cash flow of 4.25 billion.
| Operating Cash Flow | 4.62B |
| Capital Expenditures | -364.00M |
| Free Cash Flow | 4.25B |
| FCF Per Share | 184.58 |
Margins
Gross margin is 50.62%, with operating and profit margins of 22.55% and 20.53%.
| Gross Margin | 50.62% |
| Operating Margin | 22.55% |
| Pretax Margin | 21.43% |
| Profit Margin | 20.53% |
| EBITDA Margin | 24.10% |
| EBIT Margin | 22.55% |
| FCF Margin | 21.12% |
Dividends & Yields
This stock pays an annual dividend of 117.00, which amounts to a dividend yield of 1.89%.
| Dividend Per Share | 117.00 |
| Dividend Yield | 1.89% |
| Dividend Growth (YoY) | -29.94% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 93.06% |
| Buyback Yield | n/a |
| Shareholder Yield | 1.93% |
| Earnings Yield | 2.90% |
| FCF Yield | 2.98% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Sanofi India has an Altman Z-Score of 16.92 and a Piotroski F-Score of 5.
| Altman Z-Score | 16.92 |
| Piotroski F-Score | 5 |